RC
Rovin Capital Portfolio holdings
AUM
$377M
1-Year Est. Return
13.67%
This Fund
S&P 500
1 Year Est. Return
+13.67%
AUM
$377M
AUM Growth
+$15.5M
(+4.3%)
Holding
209
Top Buys
| 1 | +$6.44M | |
| 2 | +$3.5M | |
| 3 | +$2.08M | |
| 4 |
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
|
+$2.07M |
| 5 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2M |
Top Sells
| 1 | +$5.57M | |
| 2 | +$5.31M | |
| 3 | +$3.48M | |
| 4 |
BSCP
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
|
+$2.15M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.22M |
Sector Composition
| 1 | Technology | 6.95% |
| 2 | Healthcare | 6.44% |
| 3 | Communication Services | 1.82% |
| 4 | Consumer Discretionary | 1.72% |
| 5 | Financials | 1.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
201
iShares Core S&P Small-Cap ETF
IJR
$94.2B
| – | – |
-10,291
|
|
||
202
iShares Core S&P Total US Stock Market ETF
ITOT
$81.8B
| – | – |
-1,748
|
|
||
203
Manhattan Associates
MANH
$8.59B
| – | – |
-1,592
|
|
||
204
Microchip Technology
MCHP
$36.7B
| – | – |
-5,501
|
|
||
|
ONCY
205
Oncolytics Biotech
ONCY
$113M
| – | – |
-20,620
|
|
||
206
Oracle
ORCL
$445B
| – | – |
-1,548
|
|
||
207
iShares 1-3 Year Treasury Bond ETF
SHY
$24.8B
| – | – |
-2,745
|
|
||
208
Synopsys
SNPS
$84.7B
| – | – |
-677
|
|
||
209
Veeva Systems
VEEV
$32.2B
| – | – |
-1,329
|
|